Thyora Therapeutics develops precision covalent inhibitors for cancers and immune disorders, leveraging novel covalent warheads and a proprietary chemoproteomic platform to enable late-stage functionalization and discover previously undruggable targets.
| Website | http://www.thyoratx.com |
| Employees | 3 (3 on RocketReach) |
| Founded | 2026 |
| Industry | Biotechnology Research |
Looking for a particular Thyora Therapeutics employee's phone or email?
Timothy Langer is the CEO of Thyora Therapeutics.
3 people are employed at Thyora Therapeutics.
Thyora Therapeutics is based in Philadelphia, Pennsylvania.